Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 27.49% is in line with its 5-year average of 27.17%, around the middle of its 5-year range (21.05%–30.78%).
1.16% below its 12-month average of 27.81%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
27.49%
NET PROFIT MARGIN AVG TTM
27.81%
NET PROFIT MARGIN AVG 3Y
27.47%
NET PROFIT MARGIN AVG 5Y
27.17%
NET PROFIT MARGIN AVG 10Y
25.28%
NET PROFIT MARGIN AVG 15Y
19.69%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.16%
CURRENT VS 3Y AVG
+0.07%
CURRENT VS 5Y AVG
+1.16%
CURRENT VS 10Y AVG
+8.75%
CURRENT VS 15Y AVG
+39.60%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+206.12%
vs the sector median at left
Market Cap
$30.16B
Net Profit Margin
7.86%
TTM Avg
10.12%
3Y Avg
9.68%
5Y Avg
22.03%
Market Cap
$30.13B
Net Profit Margin
3.58%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zoetis Inc. (ZTS) | $30.86B | 27.49% | 27.81% | 27.47% | 27.17% |
| Biogen Inc. (BIIB)vs › | $31.40B | 8.39% | 15.03% | 17.95% | 19.29% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 7.86% | 10.12% | 9.68% | 22.03% |
| Waters Corporation (WAT)vs › | $30.13B | 3.58% | 20.93% | 21.85% | 22.39% |
| DexCom, Inc. (DXCM)vs › | $31.90B | 20.12% | 16.12% | 14.73% | 15.57% |
| Centene Corp. (CNC)vs › | $31.90B | -2.63% | -0.70% | 0.29% | 0.65% |
| ResMed Inc. (RMD)vs › | $32.06B | 26.94% | 27.08% | 24.30% | 22.30% |
| Medline Inc. (MDLN)vs › | $29.33B | 2.31% | 4.39% | 2.42% | 2.42% |
| Alcon Inc. (ALC)vs › | $33.71B | 5.92% | 9.84% | 8.46% | 5.10% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.80B | 16.82% | -1.96% | -34.26% | -68.70% |
Operating Margin
37.0%
Net Profit Margin
27.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 28.00% |
| 2026-03-31 | 26.57% |
| 2025-12-31 | 25.26% |
| 2025-09-30 | 30.04% |
| 2025-06-30 | 29.19% |
| 2025-03-31 | 28.42% |
| 2024-12-31 | 25.08% |
| 2024-09-30 | 28.56% |
| 2024-06-30 | 26.43% |
| 2024-03-31 | 27.35% |
| 2023-12-31 | 23.72% |
| 2023-09-30 | 27.71% |
| 2023-06-30 | 30.78% |
| 2023-03-31 | 27.60% |
| 2022-12-31 | 22.60% |
| 2022-09-30 | 26.42% |
| 2022-06-30 | 25.78% |
| 2022-03-31 | 29.96% |
| 2021-12-31 | 21.05% |
| 2021-09-30 | 27.74% |
| 2021-06-30 | 26.28% |
| 2021-03-31 | 29.88% |
| 2020-12-31 | 19.87% |
| 2020-09-30 | 26.82% |
| 2020-06-30 | 24.35% |
| 2020-03-31 | 27.57% |
| 2019-12-31 | 22.94% |
| 2019-09-30 | 27.34% |
| 2019-06-30 | 23.98% |
| 2019-03-31 | 21.44% |
| 2018-12-31 | 22.06% |
| 2018-09-30 | 23.45% |
| 2018-06-30 | 27.14% |
| 2018-03-31 | 25.77% |
| 2017-12-31 | 5.55% |
| 2017-10-01 | 22.12% |
| 2017-07-02 | 19.46% |
| 2017-04-02 | 19.33% |
| 2016-12-31 | 12.06% |
| 2016-10-02 | 19.26% |
| 2016-07-03 | 18.54% |
| 2016-04-03 | 17.56% |
| 2015-12-31 | 1.73% |
| 2015-09-27 | 15.57% |
| 2015-06-28 | -3.15% |
| 2015-03-29 | 14.97% |
| 2014-12-31 | 9.55% |
| 2014-09-28 | 13.72% |
| 2014-06-29 | 11.74% |
| 2014-03-30 | 14.13% |
| 2013-12-31 | 8.37% |
| 2013-09-29 | 11.88% |
| 2013-06-30 | 11.49% |
| 2013-03-31 | 12.84% |
| 2012-12-31 | -0.85% |
| 2012-09-30 | 15.90% |
| 2012-06-30 | 15.81% |
| 2012-03-31 | 10.60% |
| 2011-12-31 | 0.80% |
| 2011-09-30 | 8.96% |
| 2011-06-30 | 6.15% |
| 2011-03-31 | 7.73% |
